Durata Therapeutics, Inc. Acquisition Costs, Period Cost
Durata Therapeutics, Inc. reported Acquisition Costs, Period Cost of $8.54 million for the 38-month period ending 2012-12-31, per its 10-K filed 2013-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AcquisitionCosts · last filed 2013-03-08
- Durata Therapeutics, Inc. acquisition costs, period cost for the quarter ending 2012-12-31 was $280.00K, a 63.35% decline year-over-year.
- Durata Therapeutics, Inc. acquisition costs, period cost for the quarter ending 2012-09-30 was $277.00K, a 63.55% decline year-over-year.
- Durata Therapeutics, Inc. acquisition costs, period cost for the quarter ending 2011-12-31 was $764.00K.
- Durata Therapeutics, Inc. acquisition costs, period cost for the quarter ending 2011-09-30 was $760.00K.
- Durata Therapeutics, Inc. acquisition costs, period cost for fiscal 2012 was $1.10M, a 2.14% decline from fiscal 2011.
- Durata Therapeutics, Inc. acquisition costs, period cost for fiscal 2011 was $1.12M, a 82.21% decline from fiscal 2010.
- Durata Therapeutics, Inc. acquisition costs, period cost for fiscal 2010 was $6.30M.
| Period end | Acquisition Costs, Period Cost 3 month | Acquisition Costs, Period Cost 6 month | Acquisition Costs, Period Cost 9 month | Acquisition Costs, Period Cost 12 month | Acquisition Costs, Period Cost 32 month | Acquisition Costs, Period Cost 35 month | Acquisition Costs, Period Cost 38 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $557.00K derived: sum of 2 quarters · filed 2013-03-08 | $1.10M 10-K · filed 2013-03-08 | $8.54M 10-K · filed 2013-03-08 | |||
| 2012-09-30 | $277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $817.00K 10-Q · filed 2012-11-09 | $8.26M 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | $540.00K 10-Q · filed 2012-09-04 | $7.99M 10-Q · filed 2012-09-04 | |||||
| 2011-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $1.52M derived: sum of 2 quarters · filed 2013-03-08 | $1.12M 10-K · filed 2013-03-08 | ||||
| 2011-09-30 | $760.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $357.00K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | -$403.00K 10-Q · filed 2012-09-04 | ||||||
| 2010-12-31 | $6.30M 10-K · filed 2013-03-08 |